Alphyn
Developer of therapeutics for severe and prevalent skin diseases designed for multiple bioactive therapeutic drugs. The company's lead candidate for atopic dermatitis (AD) to treat the bacterial cause...
Valuation
$83M
Market implied
Share Price
N/A
Total Raised
$34M
Last Round
N/A